Behçet's syndrome and the nervous system

Behçet's Syndrome

Volumn , Issue , 2010, Pages 95-113

  Siva, Aksel ^a   Hirohata, Shunsei ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Beh et's disease; Classification; Differential diagnosis; Neurologic involvement; Therapy

Indexed keywords

EID: 84865349963     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-5641-5_6     Document Type: Chapter

References (74)

1. Siva A, Altintas A, Saip S (2004) Behçet's syndrome and the nervous system. Curr Opin Neurol 17:347-357
2. Hirohata S, Isshi K, Oguchi H, Ohse T, Haraoka H, Takeuchi A, Hashimoto T (1997) Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome. Clin Immunol Immunopathol 82:12-17 (Pubitemid 27049067)
3. Kawai M, Hirohata S (2000) Cerebrospinal fluid beta (2)-microglobulin in neuro-Behçet's syndrome. J Neurol Sci 179:132-139
4. Wechsler B, Vidailhet M, Bousser MG et al (1992) Cerebral venous sinus thrombosis in Behçet's disease: long term follow-up of 25 cases. Neurology 42:614-618
5. Serdaroglu P (1998) Behçet's disease and the nervous system. J Neurol 245:197-205
6. Siva A, Özdogan H, Yazici H et al (1986) Headache, neuro-psychiatric and computerized tomography findings in Behçet's syndrome. In: Lehner T, Barnes CG (eds) Recent advances in Behçet's disease. Royal Society of Medicine Service, London, pp 247-254
7. International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
8. Akman-Demir G, Serdaroglu P, Tasci B, The Neuro-Behçet Study Group (1999) Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain 122:2171-2182
9. Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behçet's syndrome. Brain 122:2183-2194
10. Siva A, Kantarci OH, Saip S et al (2001) Behçet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248:95-103 (Pubitemid 32245418)
11. Kural-Seyahi E, Fresko I, Seyahi N et al (2003) The long-term mortality and morbidity of Behçet's syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60
12. Tunc R, Saib S, Siva A, Yazici H (2004) Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome. Ann Rheum Dis 63:1693-1694 (Pubitemid 39573708)
13. Al-Araji A, Kidd DP (2009) Neuro-Behçet's disease: epidemiology, clinicalcharacteristics, and management. Lancet Neurol 8:192-204
14. Saadoun D, Wechsler B, Resche-Rigon M et al (2009) Cerebral venous thrombosis in Behçet's disease. Arthritis Rheum (Arthritis Care Res) 61:518-526
15. Yesilot N, Bahar S, Yilmazer S et al (2009) Cerebral venous thrombosis in Behçet's disease compared to those associated with other etiologies. J Neurol 256(7):1134-1142
16. Houman MH, Hamzaoui-B'Chir S, Ben Ghorbel I et al (2002) Neurologic manifestations of Behçet's disease: analysis of a series of 27 patients. Rev Med Interne 23:592-606 (Pubitemid 34764685)
17. Siva A, Saip S (2009) The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis. J Neurol 256:513-529
18. Bahar S, Coban O, Gürvit H et al (1993) Spontaneus dissection of the extracranial vertebral artery with spinal subarachnoid hemorrhage in a patient with Behçet's disease. Neuroradiology 35:352-354 (Pubitemid 23151946)
19. Krespi Y, Akman-Demir G, Poyraz M et al (2001) Cerebral vasculitis and ischaemic stroke in Behçet's disease: report of one case and review of the literature. Eur J Neurol 8(6):719-722 (Pubitemid 35015241)
20. Sagduyu A, Sirin H, Oksel F et al (2002) An unusual case of Behçet's disease presenting with bilateral internal carotid artery occlusion. J Neurol Neurosurg Psychiatry 73:343 (Pubitemid 34953659)
21. Kizilkilic O, Albayram S et al (2003) Endovascular treatment of Behçet's disease-associated intracranial aneurysms: report of two cases and review of the literature. Neuroradiology 45:328-334 (Pubitemid 36656625)
22. Aktas EG, Kaplan M, Ozveren MF (2008) Basilar artery aneurysm associated with Behçet's Disease: a case report. Turk Neurosurg 18:35-38
23. Kocer N, Islak C, Siva A et al (1999) CNS involvement in Neuro-Behçet's syndrome: an MR study. AJNR 20:1015-1024 (Pubitemid 29536207)
24. Kikuchi S, Niino M, Shinpo K et al (2002) Intracranial hemorrhage in neuro-Behçet's syndrome. Intern Med 41:692-695
25. Saip S, Siva A, Altintas A et al (2005) Headache in Behçet's syndrome. Headache 45:911-919
26. Monastero R, Mannino M, Lopez G et al (2002) Prevalence of headache in patients with Behçet's disease without overt neurological involvement. Cephalalgia 23:105-108
27. Aykutlu E, Baykan B, Akman-Demir G et al (2006) Headache in Behçet's disease. Cephalalgia 26:180-186
28. Kidd D (2006) The prevalence of headache in Behçet's syndrome. Rheumatology 45:621-623
29. Haghighi AB, Aflaki E, Ketabchi L (2008) The prevalence and characteristics of different types of headache in patients with Behçet's disease, a casecontrol study. Headache 48:424-429 (Pubitemid 351517772)
30. Hirohata S (2007) Potential new therapeutic options for involvement of central nervous system in Behçet's disease (neuro-Behçet's syndrome). Curr Rheumatol Rev 3:297-303 (Pubitemid 350142063)
31. Oktem-Tanor O, Baykan-Kurt B, Gurvit IH et al (1999) Neuropsychological follow-up of 12 patients with neuro-Behçet's disease. J Neurol 246:113-119 (Pubitemid 29184963)
32. Serdaroglu P (1989) Neuromuscular manifestations in the course of Behçet's disease. Acta Myologica 2:41-45
33. Namer IJ, Karabudak R, Zileli T et al (1987) Peripheral nervous system involvement in Behçet's disease. Eur Neurol 26:235-240
34. Lannuzel A, Lamaury I, Charpentier D, Caparros-Lefebvre D (2002) Neurological manifestations of Behçet's disease in a Caribbean population: clinical and imaging findings. J Neurol 249:410-418 (Pubitemid 34304614)
35. Sarui H, Maruyama T, Ito I et al (2002) Necrotising myositis in Behçet's disease: characteristic features on magnetic resonance imaging and a review of the literature. Ann Rheum Dis 61:751-752 (Pubitemid 34787719)
36. Atasoy HT, Tunc TO, Unal AE et al (2007) Peripheral nervous system involvement in patients with Behçet's disease. Neurologist 13:225-230 (Pubitemid 47057644)
37. Al-Araji A, Sharquie K, Al-Rawi Z (2003) Prevalence and patterns of neurological involvement in Behçet's disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry 74:608-613
38. Yesilot N, Shehu M, Oktem-Tanor O et al (2006) Silent neurological involvement in Behçet's disease. Clin Exp Rheumatol 24:S65-S70 (Pubitemid 44696881)
39. Kececi H, Akyol M (2001) P300 in Behçet's patients without neurological manifestations. Can J Neurol Sci 28:66-69 (Pubitemid 32220355)
40. Karatas GK, Onder M, Meray J (2002) Autonomic nervous system involvement in Behçet's disease. Rheumatol Int 22:155-159 (Pubitemid 35002207)
41. Huang WS, Chiu PY, Kao A, Tsai CH, Lee CC (2002) Decreased cerebral blood flow in neuro-Behçet's syndrome with neuropsychiatricmanifestations and normal magnetic resonance imaging-a preliminary report. J Neuroimaging 12:355-359
42. Nobili F, Cutolo M, Sulli A et al (2002) Brain functional involvement by perfusion SPECT in systemic sclerosis and Behçet's disease. Ann NY Acad Sci 966:409-414 (Pubitemid 34729200)
43. Cengiz N, Sahin M, Onar M (2004) Correlation of clinical, MRI and Tc-99m HMPAO SPECT findings in neuro-Behçet's disease. Cengiz N, Sahin M, Onar M. Correlation of clinical, MRI and Tc-99 m HMPAO SPECT findings in neuro-Behçet's disease. Acta Neurol Belg 104:100-105
44. Tunc T, Ortapamuk H, Naldoken S et al (2006) Subclinical neurological involvement in Behçet's disease. Neurol India 54:408-411 (Pubitemid 44870695)
45. Hirohata S (2008) Histopathology of central nervous system lesions in Behçet's disease. J Neurol Sci 267:41-47 (Pubitemid 351248903)
46. Hadfield MG, Aydin F, Lippman HR et al (1996) Neuro-Behçet's disease. Clin Neuropathol 15:249-255
47. Arai Y, Kohno S, Takahashi Y et al (2006) Autopsy case of neuro-Behçet's disease with multifocal neutrophilic perivascular inflammation. Neuropathology 26:579-585 (Pubitemid 44800296)
48. Kawakita H, Nishimura M, Satoh Y, Shibata N (1967) Neurological aspects of Behçet's disease: a case report and clinico-pathological review of the literature in Japan. J Neurol Sci 5:417-438
49. Scardamaglia L, Desmond PM, Gonzales MF et al (2001) Behçet's disease with cerebral vasculitis. Int Med J 31:560-561
50. Akman-Demir G, Tuzun E, Icoz S et al (2008) Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome. Cytokine 44:373-376
51. Hirohata S, Suda H, Hashimoto T (1998) Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behçet's disease. J Neurol Sci 159:181-185 (Pubitemid 28384527)
52. Kessler JA, Ludlam WH, Freidin MM et al (1993) Cytokine-induced programmed death of cultured sympathetic neurons. Neuron 11:1123-1132 (Pubitemid 24015286)
53. Heyser CJ, Masliah E, Samimi A et al (1997) Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci USA 94:1500-1505 (Pubitemid 27087880)
54. Gruol DL, Nelson TE (2005) Purkinje neuron physiology is altered by the inflammatory factor interlukin-6. Cerebellum 4:198-205 (Pubitemid 41354429)
55. Gadient RA, Otten UH (1997) Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog Neurobiol 52:379-390 (Pubitemid 27376652)
56. Saruhan-Direskeneli G, Yentur SP, Akman-Demir G et al (2003) Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 145:127-134 (Pubitemid 37485973)
57. Matsuo K, Yamada K, Nakajima K, Nakagawa M (2005) Neuro-Behçet's disease mimicking brain tumor. Am J Neuroradiol 26:650-653 (Pubitemid 43085974)
58. Aktas EG, Kaplan M, Ozveren MF (2008) Basilar artery aneurysm associated with Behçet's disease: a case report. Turk Neurosurg 18:35-38
59. Hisanaga K, Iwasaki Y, Itoyama Y (2005) Neuro-Sweet disease: clinical manifestations and criteria for diagnosis. Neurology 64:1756-1761 (Pubitemid 40695812)
60. Hisanaga K (2007) Neuro-neutrophilic disease: neuro-Behçet's disease and neuro-Sweet disease. Intern Med 46:153-154
61. Siva A, Fresko I (2000) Behçet's disease. Curr Treat Options Neurol 2:435-448
62. Kantarci O, Siva A (2006) Behçet's disease: diagnosis and management (Chapter 96). In: Noseworthy J (ed) Neurological therapeutics principles and practice, 2nd edn. Informa Healthcare, New York, pp 1196-1206
63. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet's disease. N Engl J Med 341:1284-1291
64. Kotake S, Higashi K, Yoshikawa K et al (1999) Central nervous system symptoms in patients with Behçet's disease receiving cyclosporine therapy. Ophthalmology 106:586
65. Mitsui Y, Mitsui M, Urakami R et al (2005) Behçet's disease presenting with neurological complications immediately after conversion from conventional cyclosporin A to microemulsion formulation. Intern Med 44:149-152 (Pubitemid 40372696)
66. Kotter I, Gunaydin I, Batra M et al (2006) CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A than under other medications results of a retrospective analysis of 117 cases. Clin Rheumatol 25:482-486 (Pubitemid 44137619)
67. Kikuchi H, Aramaki K, Hirohata S (2003) Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years. Adv Exp Med Biol 528:575-578
68. Licata G, Pinto A, Tuttolomondo A et al (2003) Anti-tumor necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome. Ann Rheum Dis 62:280-281 (Pubitemid 36238105)
69. Ribi C, Sztajzel R, Delavelle J, ChizzoliniC J (2005) Efficacy of TNF a blockade in cyclophosphamide resistant neuro-Behçet's disease. Neurol Neurosurg Psychiatry 76:1733-1735 (Pubitemid 41697647)
70. Sarwar H, McGrath H Jr, Espinoza LR (2005) Successful treatment of long-standing neuro-Behçet's disease with infliximab in patients with refractory disease. J Rheumatol 32:181-183 (Pubitemid 40092611)
71. Fujikawa K, Aratake K, Kawakami A et al (2007) Successful treatment of refractory neuro-Behçet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile. Ann Rheum Dis 66:136-137 (Pubitemid 46044876)
72. Piptone N, Olivieri I, Padula A et al (2008) Infl iximab for the treatment of neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum 59:285-290 (Pubitemid 351272967)
73. Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive Neuro-Behçet's syndrome. J Neurol Sci 272:99-105
74. Hatemi G, Silman A, Bang D et al (2008) EULAR recommendations for the management of Behçet's disease. Ann Rheum Dis 67:1656-1662